Latest News - IQVIA
Top Corporates Hub
IQVIA
IQVIA Holdings Inc. (IQV): Billionaire David Tepper Makes Minor Adjustment
07.04.2026 14:28
IQVIA Holdings Inc. (NYSE:IQV) is one of Billionaire David Tepper’s 10 Small and Midcap Stock Picks with Huge Upside Potential. IQVIA Holdings Inc. (NYSE:IQV) is a relatively recent addition to the 13F portfolio of Appaloosa Management LP. The fund first disclosed a stake in the company in the second quarter of 2025. This position comprised […]
A Look At IQVIA Holdings (IQV) Valuation After Recent Share Price Pullback
07.04.2026 10:10
IQVIA Holdings (IQV) is back on many investors’ screens after a sharp pullback, with the stock down about 29% over the past 3 months and roughly 24% year to date. See our latest analysis for IQVIA Holdings. The recent 90 day share price return of about a 29% decline and year to date share price return of about a 24% decline contrasts with a 1 year total shareholder return of 11.57%. This suggests shorter term momentum has faded even as longer term holders remain in positive territory. If...
IQVIA (IQV) Launches IQVIA.ai Unified Agentic AI Platform with Nvidia
05.04.2026 18:31
IQVIA Holdings Inc. (NYSE:IQV) is one of the best large cap value stocks to buy according to analysts. On March 16, IQVIA Holdings announced the launch of IQVIA.ai, which is a unified agentic AI platform developed in collaboration with Nvidia. The platform is purpose-built for the life sciences industry to enhance operational efficiency and decision-making […]
Reflecting On Drug Development Inputs & Services Stocks’ Q4 Earnings: IQVIA (NYSE:IQV)
02.04.2026 08:08
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services industry, including IQVIA (NYSE:IQV) and its peers.
TD Cowen Upgrades IQVIA (IQV) to Buy and Raises Price Target to $213
24.03.2026 14:43
IQVIA Holdings Inc. (NYSE:IQV) is one of the 10 Best Diagnostics and Research Stocks to Buy According to Analysts. On March 9, 2026, TD Cowen upgraded its rating on IQVIA Holdings Inc. (NYSE:IQV) from Hold to Buy. Along with the rating upgrade, the firm also raised its price target on the stock from $174 to […]
A Look At IQVIA Holdings (IQV) Valuation After Recent Share Price Weakness
23.03.2026 02:03
What IQVIA Holdings’ Recent Performance Tells You IQVIA Holdings (IQV) has attracted attention after a period of weak share performance, including a return of about 26% decline year to date and 26% decline over the past 3 months. At a last close of US$166.07 and a market value near US$27.9b, the company combines sizeable scale with a mixed recent return profile, including a 0.3% gain over the past month but a 10.7% decline over the past year. See our latest analysis for IQVIA Holdings. The...
3 Value Stocks We Steer Clear Of
20.03.2026 18:02
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.
IQVIA Holdings Inc. (IQV) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
12.03.2026 14:12
IQVIA Holdings Inc. (IQV) Barclays 28th Annual Global Healthcare Conference March 12, 2026 9:30 AM EDTCompany ParticipantsMichael Fedock - Executive VP...
Is IQVIA (IQV) Offering An Opportunity After Recent Share Price Declines?
04.03.2026 02:09
If you are wondering whether IQVIA Holdings is attractively priced right now, it helps to separate the recent share price swings from what the business might actually be worth. The stock last closed at US$173.96, with returns of 5.5% over the past 7 days, a 24.4% decline over 30 days, a 22.8% decline year to date, a 5.2% decline over 1 year, an 18.2% decline over 3 years and an 8.1% decline over 5 years, which may have shifted how investors see its potential and risk. Recent news around...
Can AI Acceleration and R&D Strength Drive VEEV Ahead of Q4 Earnings?
02.03.2026 17:13
Veeva Systems Q4 earnings are likely to benefit from Vault CRM migration, AI rollout and R&D strength.
IQVIA Acquisition Expands Drug Discovery Role And Highlights Valuation Gap
26.02.2026 06:09
IQVIA Holdings (NYSE:IQV) agreed to acquire discovery services assets from Charles River Laboratories. The deal focuses on in vitro discovery services and a small molecule AI platform that support non animal research methods. The transaction is intended to expand IQVIA's end to end drug discovery capabilities and broaden its therapeutic coverage. For investors watching NYSE:IQV, this move connects directly to IQVIA's role as a data driven partner for biopharma and healthcare clients. The...
Charles River Laboratories to Sell Certain European Assets, Businesses; Full-Year 2026 Guidance Updated
25.02.2026 13:08
Charles River Laboratories International (CRL) said Wednesday that it has agreed to sell five Europe
IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities
25.02.2026 12:00
RESEARCH TRIANGLE PARK, N.C., February 25, 2026--IQVIA Holdings Inc. ("IQVIA") (NYSE: IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced it has entered into an agreement to acquire certain discovery services assets from Charles River Laboratories.
Charles River Labs Breaks The Mold, Announces Bold Divestiture Plans
25.02.2026 10:06
Charles River to sell CDMO, Cell Solutions, and European assets, raise 2026 earnings outlook as shares trade near 52-week lows.
Charles River Laboratories To Sell Certain European Discovery Services Assets And CDMO and Cell Solutions Businesses To IQVIA In Separate Transactions
25.02.2026 08:08
Charles River Laboratories International, Inc. (NYSE:CRL) today announced that it has signed definitive agreements to sell certain European Discovery Services assets as well as the CDMO and Cell Solutions businesses in
1 Healthcare Stock to Consider Right Now and 2 We Turn Down
24.02.2026 04:44
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not only realized strong financial performance but also propelled the broader industry’s returns as healthcare stocks have gained 10.6% over the past six months while the S&P 500 was up 7.3%.
Waste Connections Stock Slides 7% Since Q4 Earnings Beat Estimates
17.02.2026 16:46
WCN shares fall 7% since fourth-quarter 2025 earnings topped estimates, as margin pressure, an operating loss and weaker recycling results weigh on sentiment.
Thursday's session: gap up and gap down stock in the S&P500 index
12.02.2026 15:35
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Thursday to find the gap up and gap down stocks in today's session.